MMP9 and breast carcinoma: The role of LCN2 in cancer metastasis is further confirmed by the fact that its deficiency in murine breast cancer cells had resulted into a significant reduction in the size and metastasis of the primary tumors with a reduced MMP9 levels in blood [260].